Sun gets US FDA approval for generic amphotericin B injection
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them
FDA changes inspection classification of the facility to Voluntary Action Indicated
In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020
The total cost of the project is estimated at Rs 30 crore
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Subscribe To Our Newsletter & Stay Updated